These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26021486)

  • 1. Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.
    Choi SA; Lee YE; Kwak PA; Lee JY; Kim SS; Lee SJ; Phi JH; Wang KC; Song J; Song SH; Joo KM; Kim SK
    Cancer Gene Ther; 2015 Jun; 22(6):302-11. PubMed ID: 26021486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma.
    Choi SA; Yun JW; Joo KM; Lee JY; Kwak PA; Lee YE; You JR; Kwon E; Kim WH; Wang KC; Phi JH; Kang BC; Kim SK
    Stem Cells Dev; 2016 Jun; 25(12):897-908. PubMed ID: 27151205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
    Choi SA; Hwang SK; Wang KC; Cho BK; Phi JH; Lee JY; Jung HW; Lee DH; Kim SK
    Neuro Oncol; 2011 Jan; 13(1):61-9. PubMed ID: 21062796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
    Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
    Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma.
    Choi SA; Lee C; Kwak PA; Park CK; Wang KC; Phi JH; Lee JY; Chong S; Kim SK
    Cancer Lett; 2019 Feb; 442():161-169. PubMed ID: 30367915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.
    Yan C; Li S; Li Z; Peng H; Yuan X; Jiang L; Zhang Y; Fan D; Hu X; Yang M; Xiong D
    Mol Pharm; 2013 Jan; 10(1):142-51. PubMed ID: 23121392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.
    Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ
    Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
    Yan C; Yang M; Li Z; Li S; Hu X; Fan D; Zhang Y; Wang J; Xiong D
    Biomaterials; 2014 Mar; 35(9):3035-43. PubMed ID: 24406219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adipose tissue-derived mesenchymal stem cells inhibit T-cell lymphoma growth in vitro and in vivo.
    Ahn JO; Chae JS; Coh YR; Jung WS; Lee HW; Shin IS; Kang SK; Youn HY
    Anticancer Res; 2014 Sep; 34(9):4839-47. PubMed ID: 25202065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
    Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
    Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
    Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
    Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
    Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
    Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A therapeutic strategy for metastatic malignant fibrous histiocytoma through mesenchymal stromal cell-mediated TRAIL production.
    Lee HJ; Yang HM; Choi YS; Park SH; Moon SH; Lee YS; Sung YC; Kim SJ
    Ann Surg; 2013 May; 257(5):952-60. PubMed ID: 23108118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
    Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
    J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886.
    Kim SM; Woo JS; Jeong CH; Ryu CH; Lim JY; Jeun SS
    Cancer Res; 2012 Sep; 72(18):4807-17. PubMed ID: 22962275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro simulation of corneal epithelium microenvironment induces a corneal epithelial-like cell phenotype from human adipose tissue mesenchymal stem cells.
    Nieto-Miguel T; Galindo S; Reinoso R; Corell A; Martino M; Pérez-Simón JA; Calonge M
    Curr Eye Res; 2013 Sep; 38(9):933-44. PubMed ID: 23767776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells.
    Casari G; Dall'Ora M; Melandri A; Masciale V; Chiavelli C; Prapa M; Neri G; Spano MC; Murgia A; D'Esposito A; Baschieri MC; Ceccherelli GB; Dominici M; Grisendi G
    Cytotherapy; 2023 Jun; 25(6):605-614. PubMed ID: 37012089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.